Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions
S Wang, W Wu, X Lin, KM Zhang, QL Wu, M Luo… - Cell & Bioscience, 2023 - Springer
The most common site of metastasis in breast cancer is the bone, where the balance
between osteoclast-mediated bone resorption and osteoblast-mediated bone formation is …
between osteoclast-mediated bone resorption and osteoblast-mediated bone formation is …
Biopsy Techniques for Musculoskeletal Tumors: Basic Principles and Specialized Techniques
AF Mavrogenis, P Altsitzioglou, S Tsukamoto… - Current Oncology, 2024 - mdpi.com
Biopsy is a pivotal component in the diagnostic process of bone and soft tissue tumors. The
objective is to obtain adequate tissue without compromising local tumor dissemination and …
objective is to obtain adequate tissue without compromising local tumor dissemination and …
Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation
Breast cancer (BC) is a malignancy that affects a large number of women around the world.
The purpose of the current study was to use bioinformatics analysis to uncover gene …
The purpose of the current study was to use bioinformatics analysis to uncover gene …
Integrated computational screening and liquid biopsy approach to uncover the role of biomarkers for oral cancer lymph node metastasis
Cancer is an abnormal, heterogeneous growth of cells with the ability to invade surrounding
tissue and even distant organs. Worldwide, GLOBOCAN had an estimated 18.1 million new …
tissue and even distant organs. Worldwide, GLOBOCAN had an estimated 18.1 million new …
Theaflavin-3-gallate, a natural antagonist for Hsp90: In-silico and in-vitro approach
Poor prognosis and metastasis have been recognized as the major cause of breast cancer
related deaths worldwide. Recent experimental evidence has shown that Hsp90, the prime …
related deaths worldwide. Recent experimental evidence has shown that Hsp90, the prime …
Genome-scan meta-analysis identifies potential biomarkers for hepatitis B and hepatitis C virus-associated hepatocellular carcinomas
Abstract Background Hepatocellular Carcinoma (HCC) is the most prevalent malignant
tumor with an elevated frequency of mortality. Around 80% of global HCC cases are caused …
tumor with an elevated frequency of mortality. Around 80% of global HCC cases are caused …
[HTML][HTML] Liquid biopsies in primary and secondary bone cancers
A Ucci, N Rucci, M Ponzetti - Cancer Drug Resistance, 2022 - ncbi.nlm.nih.gov
Liquid biopsies are a powerful tool to non-invasively analyze tumor phenotype and
progression as well as drug resistance. In the bone oncology field, liquid biopsies would be …
progression as well as drug resistance. In the bone oncology field, liquid biopsies would be …
Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients
C Ceran Serdar, Ş Osmanlıoğlu - Turkish Journal of Biochemistry, 2023 - degruyter.com
Objectives This study aims to comprehensively evaluate extracellular vesicle (EV)-based
biomarkers circulating in body fluids with significant prognostic value in breast cancer …
biomarkers circulating in body fluids with significant prognostic value in breast cancer …
Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
DY Lu, S Putta, JY Che - BME Horizon, 2023 - ojs.gs-publishing.uk
mortality for all diseases worldwide [1, 2]. Furthermore, 70-90% cancer death is caused by
neoplasm metastasis. Cancer bone metastasis is one of the highest frequent cancer …
neoplasm metastasis. Cancer bone metastasis is one of the highest frequent cancer …